ACTIVE

PHARMA FLEX

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result4,3 M €-41,4 %over 1 year
Revenue2,1 M €+10,4 %over 1 year
Equity10,5 M €+7,9 %over 1 year
Workforce3,8 ETP-11,6 %over 1 year

Identity

Source · BCE/KBO

PHARMA FLEX is a Public limited company incorporated in 2008. Its main activity is: Manufacture of other general-purpose machinery n.e.c.. Its registered office is in Nivelles. It employs on average 3,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0897.187.147
Incorporation
04/04/2008
Legal form
Public limited company
Registered office
Rue Graham Bell 8
1402 Nivelles · WallonieSee on map
Contributed capital
400 000,00 €
Latest accounts
31/12/2025
Average workforce
3,8 ETP
Joint committees (1)
  • 200
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 17 filings

Trend over 17 financial years

20252024202320222021
Income statement
Revenue2,1 M €1,9 M €2,3 M €12,7 M €13,2 M €
EBITDA79,9 k €9,5 k €-50,6 k €732,8 k €1,8 M €
Operating result38,9 k €-5,3 k €-79,9 k €155,7 k €1,3 M €
Net result4,3 M €7,4 M €5,5 M €3,7 M €4,6 M €
Balance sheet
Equity10,5 M €9,7 M €6,1 M €20,9 M €21,7 M €
Total assets14,3 M €13,8 M €18,6 M €29 M €27,3 M €
Cash1,5 M €1 M €1,9 M €5,6 M €5,9 M €
Debts3,8 M €4,1 M €12,4 M €8 M €5,5 M €
Other
Workforce3,8 ETP4,3 ETP1,0 ETP3,9 ETP3,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 2 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
AdFines1005.928.404Represented by Yvan Ferault
Director09/02/2024 → 20/06/2030
AdFinitis1012.280.815Represented by Martial Dollinger
Director09/02/2024 → 20/06/2030
NextGen Invest1004.718.674Represented by Claire Becker
Director09/02/2024 → 20/06/2030
Martial DOLLINGER
Managing directorsince 04/04/2008

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Claire BECKER
Director26/03/2014 → 2019 accounts

Other companies at this address

Rue Graham Bell 8 1402 Nivelles
CompanyCBE no.
AdFinitis● Active
1012.280.815
DOLFINANCE● Active
0444.022.844
DOLLIMMO BELGIUM● Active
0765.300.009
NextGen Invest● Active
1004.718.674
PHARMA TECHNOLOGY● Active
0443.803.803
PHARMA VAT UNIT● Active
0654.817.207

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date27/03/202615/04/202519/06/202429/06/202328/07/202228/07/2021
General meeting26/03/202626/03/202505/04/202408/06/202330/06/202224/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 17 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202526/03/202627/03/2026FrenchPDF
Full model31/12/202426/03/202515/04/2025FrenchPDF
Full model31/12/202305/04/202419/06/2024FrenchPDF
Full model31/12/202208/06/202329/06/2023FrenchPDF
Full model31/12/202130/06/202228/07/2022FrenchPDF
Full model31/12/202024/06/202128/07/2021FrenchPDF
Full model31/12/201929/06/202010/07/2020FrenchPDF
Full model31/12/201806/06/201930/07/2019FrenchPDF
Full model31/12/201707/06/201824/07/2018FrenchPDF
Full model31/12/201601/06/201726/07/2017FrenchPDF
Full model31/12/201502/06/201608/07/2016FrenchPDF
Full model31/12/201404/06/201529/07/2015FrenchPDF
Full model31/12/201305/06/201401/07/2014FrenchPDF
Abridged model30/09/201228/03/201311/04/2013FrenchPDF
Abridged model30/09/201122/03/201218/04/2012FrenchPDF
Abridged model30/09/201024/03/201124/03/2011FrenchPDF
Abridged model30/09/200925/03/201026/03/2010FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 2 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
AdFines1005.928.404Represented by Yvan Ferault
Director09/02/2024 → 20/06/2030
AdFinitis1012.280.815Represented by Martial Dollinger
Director09/02/2024 → 20/06/2030
NextGen Invest1004.718.674Represented by Claire Becker
Director09/02/2024 → 20/06/2030
Martial DOLLINGER
Managing directorsince 04/04/2008

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Claire BECKER
Director26/03/2014 → 2019 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other26/10/2026
    DIVERS
    PDF
  • Mandates24/01/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - OBJET - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates08/11/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares05/04/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates07/07/2020
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/10/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares20/12/2017
    CAPITAL, ACTIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings17 filings
Mandates
NextGen Invest
AdFines
AdFinitis
Martial Dollinger
Claire BECKER
Marthial DOLLINGER
20082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
PHARMA FLEX
Rue Graham Bell 8, 1402 Thines
Director
Director
Director
Managing director
Director
Managing director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Rue Graham Bell 8, 1402 ThinesCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00064309

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
PHARMA FLEXCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00064309

Events

  1. 2025
    Annual accounts 20254,3 M €↓
  2. 2024
    Annual accounts 20247,4 M €↑
  3. 2023
    Annual accounts 20235,5 M €↑
  4. 2022
    Annual accounts 20223,7 M €↓
  5. 2021
    Annual accounts 20214,6 M €↑
  6. 2020
    Annual accounts 20203,3 M €↑
  7. 2019
    Annual accounts 20192,3 M €↑
  8. 2018
    Annual accounts 20181,3 M €↑
  9. 2017
    Annual accounts 2017453,1 k €↓
  10. 2016
    Annual accounts 20161,1 M €↓
  11. 2015
    Annual accounts 20151,2 M €↑
  12. 2014
    Annual accounts 20141 M €↓
  13. 2013
    Annual accounts 20131,6 M €↓
  14. 2012
    Annual accounts 20122,2 M €↑
  15. 2011
    Annual accounts 20111,7 M €↑
  16. 2010
    Annual accounts 2010576,6 k €↓
  17. 2009
    Annual accounts 2009874,7 k €
  18. 04/04/2008
    IncorporationPublic limited company